OncoCyte Corporation announced that Anish John, as Chief Financial Officer, will be leaving the Company on June 15, 2023. Mr. John intends to pursue other opportunities, and there were no disagreements between the Company and Mr. John on any matter regarding its operations, policies or practices. The Company has commenced a search for a qualified replacement for Mr. John.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | -4.95% | -4.61% | +7.60% |
May. 15 | Transcript : OncoCyte Corporation, Q1 2024 Earnings Call, May 15, 2024 | |
May. 15 | Earnings Flash (OCX) ONCOCYTE CORPORATION Reports Q1 Revenue $176,000, vs. Street Est of $0.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.60% | 35.95M | |
-36.44% | 8.68B | |
-3.29% | 3.2B | |
+19.31% | 2.71B | |
-18.71% | 2.04B | |
-22.03% | 1.64B | |
+64.58% | 1.43B | |
+34.58% | 841M | |
-7.42% | 718M | |
-25.51% | 538M |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation Announces Resignation of Anish John as Chief Financial Officer, Effective from June 15, 2023